Dianthus Therapeutics, Inc. Common Stock

DNTHNASDAQ • USD
85.93 USD
↘ 3.62 (4.04%)🟢LIVE (AS OF 11:30 AM EST)
🟢Market: OPEN

Dianthus Therapeutics, Inc. Common Stock (DNTH) trades at $85.93 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Nov 16, 2026.

Open?$89.55
High?$89.83
Low?$82.78
Prev. Close?$89.55
Volume?140.0K
Avg. Volume?928.6K
VWAP?$87.15
Rel. Volume?0.15x
Bid / Ask
Bid?$75.09 × 100
Ask?$86.53 × 100
Spread?$11.44
Midpoint?$80.81
Valuation & Ratios
Market Cap?5.0B
Shares Out?56.3M
Float?50.9M
Float %?92.9%
P/E Ratio?N/A
P/B Ratio?4.06
EPS?-$3.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.
Employees
92
Market Cap
5.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2023-09-12
Address
7 TIMES SQUARE
NEW YORK, NY 10036
Phone: 929-999-4055
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
100
Momentum?
90
Short Sent.?
19
Piotroski F-Score?3/9Weak
Altman Z-Score?86.54Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?18.22%High
Short Interest?9.3M
Days to Cover?10.1
Free Float50.9M
Avg Daily Volume914.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?30.02Strong
Quick Ratio?30.02Strong
Cash Ratio?1.95Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
44
4.06FAIR▾
P/S?
Peers
100
S&P
3
1,855.34HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-21.1CHEAP▾
EV/Sales?
Peers
100
S&P
3
1,834.85HIGH▾
Returns & Efficiency
ROE?
S&P
8
-16.3%WEAK▾
ROA?
S&P
3
-15.8%WEAK▾
Cash Flow & Enterprise
FCF?$-175851000
Enterprise Value?$5.0B
Fundamentals ratios updated end of day